INTRODUCTION {#sec1-1}
============

Amebiasis caused by the protozoa *Entamoeba histolytica* is the third leading parasitic cause of death worldwide, surpassed by malaria and schistosomiasis.\[[@ref1][@ref2]\] Globally, 50 million cases are reported with a significant number of deaths. The incidence of amebiasis is higher in developing countries, and 15--20% of Indians are affected by this parasite.\[[@ref3][@ref4]\] Currently, diagnosis of amebiasis is based on microscopy, culture, isoenzyme analysis, and serology-based techniques. In addition, nested and real-time polymerase chain reaction (RT-PCR) serves as confirmatory tests for its accurate diagnosis. Though PCR and isoenzyme analysis accurately distinguish the species, they are not practical for routine use in India where amebiasis is endemic.\[[@ref5]\] The WHO has been emphasizing the need for the development of improved diagnostic methods specific for *E. histolytica* for use in the developing world.\[[@ref6]\] Recently, RT-PCR has proven to be the most sensitive method; however, it is cumbersome for routine diagnosis because of the expensive equipment and technical expertise.\[[@ref7]\] Therefore, in resource-limited nation such as India, where PCR cannot be routinely used, serology is recommended as the reliable diagnostic tool.\[[@ref8]\] Antibodies are positive at the time of clinical presentation in 60--90% cases, with positive serology in endemic areas to be 5--10%. They also act as an adjunct with other tests and useful for epidemiological studies of amebiasis.\[[@ref9]\] Thus, serological survey helps in determining the epidemiology of a disease since antibody profile in a population is a record of the present and past experience with the pathogen.\[[@ref10][@ref11]\] Hence, rapid serodiagnosis for suspected cases of amebiasis is often an important tool in clinical decision making and can be of help in the reduction of the costs of additional treatment and prolonged hospital stay.\[[@ref12][@ref3]\]

MATERIALS AND METHODS {#sec1-2}
=====================

Ethical clearance {#sec2-1}
-----------------

Serum samples were collected from patients attending the Department of Medicine and Pediatrics, JIPMER during the period of 2011--2015. In total 170 subjects who were not given any treatment before collection of blood samples were included in the study. Ethical clearance from the Institute Human Ethics Committee was obtained (EC/2011/3/4 dated 03/08/2011). Informed consent was obtained from the subjects participated in the study.

Collection of serum samples {#sec2-2}
---------------------------

About 5 ml of venous blood was collected from diseased subjects as well as healthy controls. The blood sample was centrifuged at 2500 × *g* for 15 min. The supernatant containing the serum sample was collected and stored at −80°C until further use.

Patients were categorized into following groups:

### Cases of amebic liver abscess (157) {#sec3-1}

Amoebic liver abscess (ALA) cases were diagnosed based on the following criteria: (i) Enlarged tender liver, febrile-associated toxemia, and abscess demonstrated on ultrasound; (ii) fever and pain in the epigastrium; (iii) bacteriologically sterile abscess aspirate; (v) improvement after treatment with an antiamoebic drug.

### Suspected cases of amebic liver abscess and colitis (13) {#sec3-2}

Suspected ALA cases had enlarged palpable liver, toxemia, fever, and pain in the epigastrium. Ultrasonographically, no abscess was demonstrated, and no aspiration was made in any of these cases.

### Cases of nonamoebic hepatic disorders (15) {#sec3-3}

This group comprised patients with alcoholic liver disease, hepatitis, jaundice, chronic liver disease, hepatocellular carcinoma, and cirrhosis.

### Other parasitic diseases (39) {#sec3-4}

This group included other parasitic infections such as Filariasis (18), Hydatid disease (7), neurocysticercosis (4), toxoplasmosis (9), and malaria (1).

### Presumed healthy controls (98) {#sec3-5}

These subjects aged between 20 and 45 years and their sex and profession matched those of the patients group. They had no recent history of fever, pain in epigastrium, diarrhea, and dysentery.

Serological evaluation {#sec2-3}
----------------------

A commercially available enzyme-linked immunosorbent assay (ELISA) kit (RIDASCREEN *E. histolytica* IgG, R-Biopharm, Germany, K-1721) was used for qualitative determination of IgG antibodies of *E. histolytica* in human serum. The kit includes 96 well plate coated with purified antigens, protein A conjugate, tetramethylbenzidine chromogenic substrate, buffers, and control solutions.

The test was performed as per the manufacturer\'s recommendation. Briefly, all serum samples were diluted by sample diluent in 1:50 ratio before employing for the test. 100 μl of diluted samples added into the microtiter plate along with the controls, incubated at room temperature for 15 min, then 5 times washed with wash buffer. 100 μl of protein A conjugate was added, incubated for 15 min and washed five times with buffer. 100 μl of substrate was added, incubated for 15 min, to which 50 μl of stop solution was added. Optical density was measured at 450 nm (reference filter 620 nm).

Statistics {#sec2-4}
----------

The Z-test (converted to *P* value) and unpaired Student\'s *t*-test were used to determine the significance of differences. Sensitivity was calculated as follows: Number of patients with positive test results/total number of patients ×100. Specificity was calculated as follows: Number of controls with negative test results/total number of controls ×100. The positive predictive value was calculated as follows: Number of true positives/(number of true positives + number of false positives) ×100. The negative predictive value was calculated as follows: Number of true negatives/(number of true negatives + number of false negatives) ×100. The positive predictive value defines the probability of patients having a disease if the test is positive. The negative predictive value defines the probability of patients not having amebiasis if the test is negative.

RESULTS {#sec1-3}
=======

The sample index was interpreted by calculating the average absorbance of the negative control. 0.15 was added to the average absorbance which yielded the cutoff value for the test. Sample index was obtained by dividing the absorbance for the sample by the cutoff value.

Out of 322 samples tested, 108 were positive and 214 were negative by RIDASCREEN IgG antibody ELISA. Among the cases of confirmed liver abscess, 94 (59.87%) were positive. In suspected liver abscess group, 2 (15.38%) out of 13 were positive. 5 (33.33%) out of 15 were positive among the cases of nonamoebic hepatic disorders while 5 (12.82%) out of 39 were positive in other parasitic infection group. Among the presumed healthy controls, 2 (2%) out of 98 were positive \[[Table 1](#T1){ref-type="table"}\].
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At 95% confidence interval, the overall sensitivity of RIDASCREEN *E. histolytica* IgG antibody ELISA was evaluated to be 56.47% while specificity to be around 92.11%. The positive predictive value was found to be 88.89% and negative predictive value 65.42%. The overall disease prevalence was calculated to be 52.8%.

DISCUSSION {#sec1-4}
==========

The traditional way for diagnosis of amebiasis still depends on microscopy in laboratories where molecular techniques are still not employed. This technique is tedious, time-consuming, and requires a highly skillful technician. However, extraintestinal amebiasis is often characterized by the absence of cyst in stool. In such cases diagnosis mainly depends on the clinical picture. Hence, often cases are either misdiagnosed or missed out.\[[@ref13]\] Therefore, in developing nation such as India, where molecular techniques cannot be used routinely, serological methods comes as an aid in the diagnosis of amebiasis.

Serological assays include indirect hemagglutination assay, Latex agglutination assay, complement fixation test, counterimmunoelectrophoresis, gel diffusion, indirect fluorescence assay, and ELISA. Among them, ELISA is considered to be one of the most popular diagnostic methods, and the kinetics of antibody response of *E. histolytica* has been well-elucidated in the recent past. It has been reported that sensitivity of detection to specific antibodies from serum in *E. histolytica* is 100%. Furthermore, in 95% cases of amebic colitis and ALA, serum IgG antibody was found to be present within 1 week after the onset of symptoms. Hence, ELISA has been used to study the epidemiology of asymptomatic and symptomatic amebiasis after fecal examination. It is also useful in the evaluation of intestinal and extraintestinal infections where amebiasis is suspected, but organism cannot be detected in feces.\[[@ref14][@ref15]\]

Many commercially available ELISA kits with varied sensitivity and specificity have been reported. In our study, RIDASCREEN Entamoeba IgG ELISA kit which has been reported with 97--100% sensitivity and 95--97% specificity has been employed. Our study reported 94 positive out of 157 in ALA group and 2 positive out of 13 suspected amebiasis group though most of the cases have been clinically proven to be ALA. In a previous study reported from JIPMER using TECHLAB ELISA kit, 29/45 (64.4%) cases were reported to be positive.\[[@ref11]\] The reason for low detection rate of IgG antibody may be because samples have been collected from patient immediately after the onset of the disease. In control group of nonamoebic hepatic disorders 5/15, other parasitic disorders 5/39, and healthy control 2/98 were seropositive for *E. histolytica* IgG antibody. In an endemic country such as India, most of the people are exposed to *Entamoeba* infection and remain asymptomatic. Though some cases are positive in the control groups, there is a chance of these people being exposed to the infection. Though the kit has been reported to have very high sensitivity and specificity, our study reported to have sensitivity of 56% and specificity of 92%. Thus, ELISA can be used as a routine surveillance test in a clinical setup to detect amebiasis if the cases are judicially evaluated along with the other routine tests.
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